Resources for Opioid Treatment Providers
Resources are available to assist you on your path to recovery. Enter your address, city or ZIP code to locate treatment centers nearest to you.
PLEASE NOTE: Your personal information and the search criteria you enter into the locator are secure and anonymous. HHS does not collect or maintain any information you provide.
Federal Guidelines for Opioid Treatment Programs
A manual for the operation of opioid treatment programs (OTPs). This guidance covers patient assessment, treatment planning, medication-assisted treatment (methadone and buprenorphine), overdose and relapse prevention, and recovery care.
Apply for Opioid Treatment Program (OTP) Certification
Certification is required to dispense medications for the treatment of substance use disorders.
- Submit an Opioid Treatment Exception Request
- There are federal standards for the administration and management of opioid treatment. Any deviation from the opioid treatment standards requires the submission and approval of an exception request.
Training Materials and Provider Resources for Medication-Assisted Treatment (MAT)
Collection of training materials and data for medical professionals including OTP certification application information and other resources on MAT.
- Medication-Assisted Treatment of Opioid Use Disorder: Pocket Guide
- Mobile App for Practitioners Who Provide Medication-Assisted Treatment
- All SAMHSA publications for Medication-Assisted Treatment
TIP 63: Medications for Opioid Use Disorders
Guidance for healthcare professionals and addiction treatment providers on appropriate prescribing practices for the treatment of OUD. TIP 63 also educates patients, families, and the general public about how OUD medications work and the benefits they offer.
Telemedicine and Prescribing Buprenorphine for the Treatment of Opioid Use Disorder
HHS is working with the Drug Enforcement Administration (DEA) to understand how telemedicine can best be leveraged to expand buprenorphine-based Medication Assisted Treatment (MAT). HHS has developed a clinical case scenario to provide clinicians with an example of clinical practice engagement consistent with the DEA Statement and applicable HHS administered authorities.
Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
This guidance publication supports practitioners in addressing the needs of pregnant women with opioid use disorders and their infants and families.
Narcotic Treatment Programs Best Practice Guideline
The Drug Enforcement Administration (DEA) presents best practices for each aspect of narcotic treatment programs (NTPs) to assist in complying with existing laws and regulations. Topics include ordering medication, dispensing medication, recordkeeping, and security measures.
Implementing Medication-Assisted Treatment for Opioid Use Disorder in Rural Primary Care: Environmental Scan
The purpose of this environmental scan was to explore the unique factors associated with implementing MAT in rural primary care settings and the availability of necessary tools.
- DEA Diversion Control Division E-mail Statement: Use of Telemedicine While Providing MAT
- HHS Clinical Case Scenario